RVLPQ — RVL Pharmaceuticals Share News
0.000.00%
Last trade - 00:00HealthcareHighly SpeculativeMicro Cap
- $0.00m
- $38.61m
- $49.72m
Brief: RVL Pharmaceuticals Says Co Issued Petition In Central Office Of High Court In Ireland To Wind Up Company
Brief: RVL Completes Financial Restructuring
Brief: Rvl Pharmaceuticals PLC Received Delisting Notice From Listing Qualifications Department Of Nasdaq Stock Market Llc
U.S. STOCKS ON THE MOVE-Cerevel Therapeutics, Scholar Rock, Helius
U.S. STOCKS ON THE MOVE-Scholar Rock, Target, LL Flooring
RVL Pharma plummets on bankruptcy reorganization plan
Brief: RVL Pharmaceuticals Announces Prepackaged Reorganization Of Certain U.S. Subsidiaries
RVL Pharmaceuticals PLC reports results for the quarter ended in June - Earnings Summary
RVL Pharmaceuticals PLC expected to post a loss of 11 cents a share - Earnings Preview
U.S. STOCKS ON THE MOVE-Rivian, Alphabet, Moderna
U.S. STOCKS ON THE MOVE-C4 Therapeutics, Pegasystems, BioMarin Pharma
U.S. STOCKS ON THE MOVE-Moderna, Netflix, Coinbase
RVL Pharmaceuticals gains on exploring strategic alternatives
Brief: RVL Pharmaceuticals Provides Business Update
Brief: Rvl Pharmaceuticals PLC Receives Notice Of Delisting Or Failure To Satisfy A Continued Listing Rule Or Standard From Nasdaq
RVL Pharmaceuticals PLC reports results for the quarter ended in March - Earnings Summary
Brief: Rvl Pharmaceuticals PLC Reports Q1 2023 Financial Results, Provides Commercial Update
RVL Pharmaceuticals PLC expected to post a loss of 12 cents a share - Earnings Preview
RVL Pharmaceuticals PLC reports results for the quarter ended in December - Earnings Summary